STXS.US Stereotaxis Inc

Healthcare Health Care Equipment & Supplies USA Stocks
0.8821 USD
Close of Nov 18, 2026
0.8000 2.86
Market cap
USD 88.9M
P/E
-
P/B
3.79x
ROE
-104.9%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is STXS.US undervalued?

Graham number

The Graham number of Stereotaxis Inc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Stereotaxis Inc fundamental analysis

No fundamental analysis for Stereotaxis Inc yet.

Stereotaxis Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Stereotaxis Inc

Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. The company offers robotic magnetic navigation (RMN) systems, such as Genesis RMN, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters through the blood vessels and chambers of the heart to treatment sites; and GenesisX RMN System…

Full company profile